Status: current, estado de definición: concepto suficientemente definido. Date: 31-Jul 2018. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | producto que contiene fluocinolona y neomicina en forma farmacéutica para administración cutánea como únicos ingredientes (forma farmacéutica de producto medicinal) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | adopta un rol | rol terapéutico antibacteriano | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | preparado compuesto con neomicina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | producto con fluocinolona | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene como ingrediente activo | antiinfeccioso cutáneo | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene como ingrediente activo | Neomycin (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene como ingrediente activo | Fluocinolone (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene como ingrediente activo | corticosterona | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene como ingrediente activo | agente hormonal suprarrenal (sustancia) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene como ingrediente activo | antinfeccioso local (sustancia) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene como ingrediente activo | bactericida | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | producto con fluocinolona y neomicina | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | forma farmacéutica cutánea Y/O transdérmica (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Ointment | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | producto que contiene fluocinolona en forma farmacéutica para administración tópica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | ungüento cutáneo (forma farmacéutica) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | producto que contiene neomicina en forma farmacéutica para administración tópica (forma farmacéutica de producto medicinal) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene valor de denominador de potencia de concentración | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | recuento de bases de ingrediente activo | 2 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Fluocinolone acetonide (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene base de sustancia de la potencia | sulfato de neomicina | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene valor de numerador de potencia de concentración | 250 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | sulfato de neomicina | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene base de sustancia de la potencia | Fluocinolone acetonide (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | tiene valor de numerador de potencia de concentración | 5 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets